www.law360.com/cases/559431ffcc4ad12681000001

Parties, docket activity and news coverage of federal case ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company et al, case number ...

law.justia.com/cases/florida/supreme-court/1997/90001-0.html

Wood v. Eli Lilly & Co. - 701 So. 2d 344. ... ELI LILLY & CO., etc., et al., Appellees. ... Leigh of English, McCaughan & O'Bryan, P.A., Fort Lauderdale, for Appellee Eli Lilly and Company. .... OVERTON, SHAW, HARDING and WELLS, JJ., concur.

law.justia.com/cases/michigan/supreme-court/1984/64712-4.html

Abel v. Eli Lilly & Co. - 343 N.W.2d 164, 418 Mich. 311. ... Plaintiffs' initial complaint stated that all the plaintiffs' mothers had ingested one of seven synthetic ...

casetext.com/case/nail-v-eli-lilly-co-in-re-darvocet

Mar 8, 2013 ... They assert that Plaintiff Sharon Collins in Shaw, et al. v. Eli Lilly and Company, et al., Civil Action No. 2: 12-243-DCR, "has indicated that she ...

e-foia.uspto.gov/Foia/RetrievePdf?system=FCA&flNm=08-1248_1

Mar 22, 2010 ... v. ELI LILLY AND COMPANY,. Defendant-Appellant. John M. Whealan, of Silver Spring, ... The Regents of the University of California, et al. ... William P. Atkins, Pillsbury Winthrop Shaw Pittman LLP, of McLean, Virginia, for.

seekingalpha.com/article/4218863-eli-lilly-and-co-lly-q3-2018-results-earnings-call-transcript

Nov 6, 2018 ... (NYSE:LLY) Q3 2018 Earnings Call November 6, 2018 9:00 AM ET ... At this time, all participants are in a listen-only mode. ... Thank you for joining us for Eli Lilly & Company's Q3 2018 Earnings Call. ... Enrique Conterno, the President of Lilly Diabetes and Lilly U.S.A.; Christi Shaw, the President of Lilly Bio ...

www.ncbi.nlm.nih.gov/pmc/articles/PMC2696350

For AD vs MCI: p < 0.005, tau; p < 0.05, amyloid–β 1 to 42 peptide (Aβ1–42); p < 0.01, tau ..... Research, Bristol-Myers Squibb, Eli Lilly & Company, GlaxoSmithKline, Merck & Company, AstraZeneca AB, ... Shaw LM, Korecka M, Clark CM, et al.

www.prnewswire.com/news-releases/lillys-taltz-ixekizumab-receives-us-fda-approval-for-the-treatment-of-active-psoriatic-arthritis-300565484.html

Dec 1, 2017 ... 1, 2017 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) ... living with the disease," said Christi Shaw, president, Lilly Bio-Medicines. "We are ... SPIRIT-P1: 58 percent of patients treated with Taltz vs. .... 2 Ritchlin C, et. al.

professional.heart.org/idc/groups/ahamah-public/@wcm/@sop/@scon/documents/downloadable/ucm_489901.pdf

Johnson & Johnson Corporation. Portola Pharmaceuticals ... Eli Lilly and Company. The Medicines ... Shaw et al. Circ Res. 2008 .... 2g v Placebo. 6g v Placebo.